Bank of New York Mellon Plans to Raise Q3 Dividend-March 2024-www.financetom.com

Bank of New York Mellon Plans to Raise Q3 Dividend

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Bank of New York Mellon Plans to Raise Q3 Dividend

Jul 1, 2025 2:37 PM

05:24 PM EDT, 07/01/2025 (MT Newswires) -- Bank of New York Mellon ( BK ) said late Tuesday its preliminary Stress Capital Buffer requirement will remain 2.5%, equal to the regulatory floor, following its 2025 bank stress test process.

The company said it plans to raise its quarterly dividend to $0.53 per share from $0.47, starting Q3.

Previous page： BRIEF-Mynd.ai Completes the Acquisition of Award-Winning AI Voice and Remote Control Technology Next page： Cenovus Energy Up 1.5% In US Premarket As Sells Stake in WRB Refining to Phillips 66 For US$1.4 Billion

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

BRIEF-Mynd.ai Completes the Acquisition of Award-Winning AI Voice and Remote Control Technology

Sep 9, 2025

Sept 9 (Reuters) - Mynd.ai Inc: * MYND.AI COMPLETES THE ACQUISITION OF AWARD-WINNING AI VOICE AND REMOTE CONTROL TECHNOLOGY Source text: Further company coverage: ...

Cenovus Energy Up 1.5% In US Premarket As Sells Stake in WRB Refining to Phillips 66 For US$1.4 Billion

Sep 9, 2025

08:11 AM EDT, 09/09/2025 (MT Newswires) -- Cenovus Energy ( CVE ) was at last look up 1.5% in US premarket after saying Tuesday it is selling its 50% interest in WRB Refining to its joint venture partner Phillips 66 for US$1.4 billion in cash. The WRB joint venture includes the Wood River Refinery in Illinois and the Borger Refinery...

Novartis To Expand Heart Drug Portfolio With $1.4 Billion Tourmaline Bio Acquisition

Sep 9, 2025

Tourmaline Bio, Inc. ( TRML ) shares surged Tuesday after Novartis AG ( NVS ) announced a $1.4 billion acquisition of the U.S.-based biotech, strengthening the Swiss drugmaker’s pipeline of cardiovascular and kidney treatments. Novartis ( NVS ) will pay $48.00 per share in cash at closing, a 59% premium to Tourmaline’s September 8 closing price and 127% above its...

Colliers Buys Greystone Sales Group

Sep 9, 2025

08:13 AM EDT, 09/09/2025 (MT Newswires) -- Colliers International Group ( CIGI ) said Tuesday it has acquired Greystone Sales Group. The acquisition expands Colliers' multifamily sales capabilities, the company said. Financial terms were not disclosed. ...